Purchases and Sales Made in Q2 2024 in Olema Pharmaceuticals, Inc. (OLMA)
This table provides information about the institutional ownership of Olema Pharmaceuticals, Inc. (OLMA) during Q2 2024. The information is specifically focused on institutions that hold shares of Olema Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-35.9K- 8.22% |
$314K - $503K
|
401K
$1.83M
|
|
Aug 14, 2024
Q2 2024
|
Atom Investors LP
Austin, TX |
SELL
|
- |
-59.8K- 63.41% |
$522K - $837K
|
34.5K
$158K
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-86.9K- 42.63% |
$759K - $1.22M
|
117K
$534K
|
|
Aug 14, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-98.1K- 75.71% |
$857K - $1.37M
|
31.5K
$144K
|
|
Feb 07, 2025
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-98.1K- 75.71% |
$857K - $1.37M
|
31.5K
$144K
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-104K- 84.83% |
$905K - $1.45M
|
18.5K
$84.7K
|
|
Aug 14, 2024
Q2 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-135K- 29.35% |
$1.18M - $1.89M
|
325K
$1.49M
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-157K- 86.82% |
$1.37M - $2.2M
|
23.9K
$109K
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-163K- 32.63% |
$1.42M - $2.27M
|
336K
$1.53M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-163K- 32.63% |
$1.42M - $2.27M
|
336K
$1.53M
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-193K- 65.39% |
$1.68M - $2.7M
|
102K
$466K
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-193K- 59.18% |
$1.69M - $2.71M
|
133K
$610K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-226K- 90.5% |
$1.97M - $3.16M
|
23.8K
$109K
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-251K- 12.98% |
$2.19M - $3.51M
|
1.68M
$7.7M
|
|
Aug 14, 2024
Q2 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-442K- 67.1% |
$3.85M - $6.18M
|
217K
$989K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-648K- 83.06% |
$5.66M - $9.07M
|
132K
$604K
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-689K- 67.24% |
$6.01M - $9.64M
|
336K
$1.53M
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.17M- 95.42% |
$10.2M - $16.3M
|
56K
$256K
|
|
Aug 14, 2024
Q2 2024
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-1.18M- 26.8% |
$10.3M - $16.4M
|
3.21M
$14.7M
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.23M- 38.71% |
$10.7M - $17.2M
|
1.95M
$8.9M
|